Development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung

PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.

 
 

Latest news from PneumoNP

ENF2017_logo_web-red

Meet us at EuroNanoForum 2017

Iraida Loinaz, coordinator of the PneunoNP project, attends the EuroNanoForum 2017 conference. EuroNanoForum 2017 is an international event that focus ...
Read More
medic-563425_960_720

Confront antibiotic resistance with a better diagnostic system

To slow down the rise of non-curable infections, a Dutch company developed a diagnostic kit to identify strains of antibiotic-resistant ...
Read More